Seven markers were differentially abundant between CAP groups, wherein differences almost exclusively were driven by COVID-19; E-selectin was the only differentially abundant endothelial marker in non-COVID-19 CAP patients (higher CAP-strep than in CAP-flu, P<0·05) (Figure 3a+b). Here, SELE is linked to COVID-19.